Key result
Etomidate was successfully used as an alternative anaesthetic agent for electroconvulsive therapy in three patients with high seizure thresholds, adverse effects to thiopental, or severe cardiac disease.
Why the study?
Does etomidate provide a safe and effective anaesthetic option for specific patients undergoing electroconvulsive therapy?
Population
3 individuals undergoing electroconvulsive therapy, including one requiring maximum electrical stimulus, one…
Design
Case_series
Authors
Loading...
May support etomidate for ECT in select high-risk patients; leaves open confirmation in prospective trials.
Case Report (n=3)
No
Does etomidate provide a safe and effective anaesthetic option for specific patients undergoing electroconvulsive therapy?
Etomidate may be a useful anaesthetic agent for ECT in specific patient populations, such as those with severe cardiac disease or intolerance to other agents.
Benbow et al. (2002) conducted a case report in Depression requiring electroconvulsive therapy (n=3). Etomidate vs. Thiopental (prior use) was evaluated on Clinical improvement and adequate seizure duration. Etomidate was successfully used as an alternative anaesthetic agent for electroconvulsive therapy in three patients with high seizure thresholds, adverse effects to thiopental, or severe cardiac disease.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: